We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$23.9B
AUM Growth
+$1.43B
Cap. Flow
-$1.37B
Cap. Flow %
-5.75%
Top 10 Hldgs %
23.75%
Holding
1,048
New
64
Increased
472
Reduced
416
Closed
27

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$114M
2
MA icon
Mastercard
MA
+$36.5M
3
IQV icon
IQVIA
IQV
+$24.7M
4
JD icon
JD.com
JD
+$21.2M
5
SE icon
Sea Limited
SE
+$19M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$148M
2
LIN icon
Linde
LIN
+$94.3M
3
QGEN icon
Qiagen
QGEN
+$65.9M
4
AAPL icon
Apple
AAPL
+$53.3M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Financials 13.47%
3 Healthcare 11.82%
4 Consumer Discretionary 11.25%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRL icon
526
Hormel Foods
HRL
$13.8B
$5.13M 0.02%
105,165
+18,440
+21% +$808K
CZR icon
527
Caesars Entertainment
CZR
$6.14B
$5.13M 0.02%
54,830
-5,709
-9% -$579K
AVY icon
528
Avery Dennison
AVY
$13.4B
$5.11M 0.02%
23,578
-247
-1% -$52.8K
HDB icon
529
HDFC Bank
HDB
$121B
$5.1M 0.02%
156,652
+6,576
+4% +$230K
MKL icon
530
Markel Group
MKL
$23.2B
$5.04M 0.02%
4,080
-49
-1% -$61.8K
GGG icon
531
Graco
GGG
$13.5B
$5.02M 0.02%
62,316
+8,182
+15% +$621K
PBA icon
532
Pembina Pipeline
PBA
$27.6B
$5.01M 0.02%
165,185
-3,247
-2% -$103K
CTVA icon
533
Corteva
CTVA
$51.3B
$5.01M 0.02%
105,898
-19,641
-16% -$894K
GEN icon
534
Gen Digital
GEN
$17.5B
$5M 0.02%
192,425
-15,433
-7% -$391K
GNTX icon
535
Gentex
GNTX
$5.07B
$4.98M 0.02%
142,842
+14,609
+11% +$518K
FBIN icon
536
Fortune Brands Innovations
FBIN
$6.06B
$4.98M 0.02%
54,476
+4,936
+10% +$427K
RNG icon
537
RingCentral
RNG
$5.28B
$4.88M 0.02%
26,072
-11,576
-31% -$2.57M
WHR icon
538
Whirlpool
WHR
$2.82B
$4.84M 0.02%
20,637
+1,884
+10% +$414K
ZEN
539
DELISTED
ZENDESK INC
ZEN
$4.83M 0.02%
46,343
+5,919
+15% +$635K
BMRN icon
540
BioMarin Pharmaceuticals
BMRN
$12.4B
$4.82M 0.02%
54,524
-1,309
-2% -$108K
OXY icon
541
Occidental Petroleum
OXY
$55.9B
$4.81M 0.02%
165,784
+21,943
+15% +$689K
AES icon
542
AES
AES
$10.5B
$4.8M 0.02%
197,739
-4,398
-2% -$107K
CAG icon
543
Conagra Brands
CAG
$7.23B
$4.78M 0.02%
140,011
-3,380
-2% -$111K
MTN icon
544
Vail Resorts
MTN
$5.3B
$4.75M 0.02%
14,483
+2,282
+19% +$778K
AAP icon
545
Advance Auto Parts
AAP
$3.49B
$4.72M 0.02%
19,689
-340
-2% -$77.7K
BCE icon
546
BCE
BCE
$21.2B
$4.7M 0.02%
90,348
-14,359
-14% -$734K
EVRG icon
547
Evergy
EVRG
$19.2B
$4.7M 0.02%
68,465
-1,632
-2% -$106K
OMC icon
548
Omnicom Group
OMC
$23.4B
$4.67M 0.02%
63,803
-1,329
-2% -$94.5K
CHRW icon
549
C.H. Robinson
CHRW
$17.5B
$4.67M 0.02%
43,365
+2,976
+7% +$289K
CVE icon
550
Cenovus Energy
CVE
$52.1B
$4.62M 0.02%
377,188
-7,976
-2% -$95.5K

Similar funds

Aviva's Q4 2021 Portfolio in Review

As of Q4 2021, Aviva held 1,048 positions worth $23.9B, up 6.4% from $22.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva withdrew a net $1.37B in Q4 2021, closing 27 positions and reducing 416 holdings. Its most notable exit was Coresite Realty Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Aviva opened a new position in Rivian worth $4.38M.

  • Aviva's largest Q4 2021 buy was Rivian: 42,209 shares worth $4.38M.
  • Aviva added most to American Tower in Q4 2021, an estimated $114M increase.
  • Aviva's biggest Q4 2021 reduction was Stellantis, cutting an estimated $148M.
  • Aviva fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $33.7M.
  • Aviva's ten largest holdings make up 24% of its $23.9B portfolio in Q4 2021.
  • Aviva opened 64 new positions and closed 27 in Q4 2021.
  • Aviva's portfolio value rose 6.4% quarter-over-quarter to $23.9B.

Based on Aviva's 13F filing for Q4 2021, filed 10 Feb 2022.